Myomo, Inc. (MYO) fundamentals score
Myomo is a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. It develops and market the MyoPro product line. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Healthcare · Listed on NYSE
Overall: 5.2 out of 10, Mixed fundamentals
- Growth: 6.1/10
- Profitability: 2.5/10
- Financial health: 5.1/10
- Earnings quality: 7.5/10
- Valuation: 5.7/10
Scores are calculated from Myomo, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10